Saratov JOURNAL of Medical and Scientific Research

The effect of changes in homeostatic constants of blood parameters in patients with cardioembolic stroke on the clinical course and prognosis of the disease

Year: 2020, volume 16 Issue: №1 Pages: 384-388
Heading: Neurology Article type: Original article
Authors: Khakhanova O.N., Skorokhodov А.Р., Kutashov V.A., Ulyanova O.V.
Organization: Federal State Institution "416 Military Hospital", Voronezh State Medical University n.a. N.N. Burdenko
Summary:

Objective: to assess the effect of changes in homeostatic constants of blood parameters in patients with cardioembolic stroke (CEI) on the clinical course and prognosis of the disease. Material and Methods. 90 patients were treated and examined in the acute period of CEI: 60 patients were discharged (main group) and 30 died (control group). A detailed study was made: general blood count, hemostasis, and biochemical changes in the blood. Neurological deficit was evaluated according to the NIHSS, Rivermead, and Rankin scales. Results. All homeostatic blood constants are higher than normal in patients who died compared to survivors (p <0.05). In patients with mortality on the first day, changes in blood biochemical parameters are more pronounced than in patients who died at a later date. The most pronounced changes in the biochemical analysis of blood (glucose, urea, creatinine, AsAT, AIAT), acid-base imbalance are associated with severe clinical manifestations of CEI and a high probability of death. The diabetes mellitus in patients with CEI is a kind of pathognomonic sign, marker and predictor of adverse outcome. Metabolic acidosis prevailed in the group of deceased patients, and respiratory acidosis prevailed in the group of survivors. Conclusion. Marked changes in homeostatic blood constants and pronounced neurological deficit at the time of the development of the disease are associated with severe clinical manifestations of CEI and a high probability of death.

Bibliography:
1. Skorokhodov АР, Khakhanova ON, Kutashov VA. Risk factors affecting the outcome of cardioembolic stroke. Applied Informational Aspects of Medicine 2016; 19 (1): 113-8.
2. Geraskina LA. Cardioembolic stroke: the diversity of the causes and current approaches to prevention. Neurology Neuropsychiatry, Psychosomatics 2013; (4): 60-5.
3. Khakhanova ON, Skorokhodov АР, Kutashov VA, Ulyanova OV. Cardioembolic stroke: risk factors, prognosis, secondary prevention. Saratov Journal of Medical Scientific Research 2017; 13 (1): 187-92.
4. Gafarova ME, Domashenko MA, Korobkova DZ, et al. Hemorheology and hemostasis in patients with ischemic stroke during thrombolytic therapy. Annals of Clinical and Experimental Neurology 2015; 9 (1): 4-11.
5. Maksimova MYu, Suslina ZA, lonova VG. Hemorheology and hemostasis in the acute period of lacunar stroke. S.S. Korsakov Journal of Neurology and Psychiatry 2007; 12: 4-7.
6. Kuznetsov AN, Vinogradov Ol, Rybalko NV. Modern approaches to antithrombotic therapy in patients with cardioembolic stroke. Neurology, Neuropsychiatry, Psychosomatics. 2013; (2): 28-39.
7. Fonyakin AV, Geraskina LA, Suslin ZA. Cardiac pathology in various pathogenic subtypes of ischemic stroke. Clinical Medicine 2002; (1): 25-8.
8. Parfenov VA, Khasanova DR. Ischemic stroke. Moscow: MIA, 2012; 288 p.
9. Strong К, Mathers С, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007; 6: 182-7.
10.Azhermacheva MN, Plotnikov DM, Aliev Ol, et al. The rheological properties of blood in the most acute stage of ischemic stroke and their relation to the severity of neurological impairment. Bulletin of Siberian Medicine 2013; 12 (5): 5-12.

AttachmentSize
2020_01-3_384-388.pdf314.51 KB

No votes yet